Europe bio-implants market is expected to reach USD 81,071.78 million by 2025 growing at a CAGR of 7.6% in the forecast period 2018 to 2025.
The major factors driving the growth of this market are rising number of aging and geriatric population, changing lifestyle problems, rising incidence of chronic diseases, increasing awareness about cosmetic implants, technological advancement in implants, rising demand for non-surgical bio-implants are the factors which is driving the growth of the market.
The key market players for Europe Bio-Implants Market are listed below;

Abbott Laboratories
Medtronic
Boston Scientific Corporation
Bio-Rad Laboratories, Inc.
Somnomed Limited
Johnson & Johnson Services, Inc.
Edwards Lifesciences Corporation
F. Hoffmann-La Roche AG
C.R. Bard, Inc.
Mimedx Group, Inc.
Biotronik Se & Co.Kg

The market is further segmented into;
Product Type
Type
Material
Mode of Administration
End-user

The Europe bio-implants market is segmented based on product type into orthopedics & trauma, pacing devices, stents & related implants, spinal implants, ophthalmic implants, structural cardiac implants, dental implants, neurostimulators implants, prosthetic implants, and others. In 2018, orthopedics and trauma segment is expected to dominate the Europe bio-implants market with 24.9% market share and is expected to reach USD 21,326.30 million by 2025, growing at the highest CAGR of 8.5% in the forecast period 2018 to 2025.
The Europe bio-implants market is segmented on the basis of type into allograft, autograft, xenograft, synthetic, and others. In 2018, Allograft segment is expected to dominate the Europe bio-implants market with 42.9% market share and is expected to reach USD 35,618.07 million by 2025, growing at the highest CAGR of 8.0% in the forecast period 2018 to 2025.
The Europe bio-implants market is segmented on the basis of material into biomaterial metal, alloy, polymers, ceramics, and acrylic hydrogel. In 2018, Biomaterial Metal segment is expected to dominate the Europe bio-implants market with 31.9% market share and is expected to reach USD 26,010.99 million by 2025, growing at CAGR of 7.7% in the forecast period 2018 to 2025. However, Alloy is expected to grow at the highest CAGR of 8.1% in the forecast period, and is expected to reach USD 22,151.57 million in 2025 from USD 11,977.65 million in 2017.
The Europe bio-implants market is segmented on the basis of mode of administration into surgical and non-surgical. In 2018, surgical segment is expected to dominate the Europe bio-implants market with 60.7% market share and is expected to reach USD 48,127.54 million by 2025, growing at CAGR of 7.3% in the forecast period 2018 to 2025. However, Non-surgical is expected to grow at the highest CAGR of 8.1% in the forecast period, and is expected to reach USD 32,944.23 million in 2025 from USD 17,768.17 million in 2017.
The Europe bio-implants market is segmented on the basis of end users into hospitals, ambulatory surgical centers, clinics, and others. In 2018, Hospital segment is expected to dominate the Europe bio-implants market with 46.2% market share and is expected to reach USD 38,029.02 million by 2025, growing at the highest CAGR of 7.9% in the forecast period 2018 to 2025.
Based on geography, the Europe bio-implants market is segmented into geographical regions, such as,
Germany,
United Kingdom,
France,
Spain,
Italy,
Russia,
Turkey,
Belgium,
Nether lands,
Switzerland,
Rest of Europe
Covered in this report
The report covers the present scenario and the growth prospects of the Europe bio-implants market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.